搜尋
Virax Biolabs Group Ltd
VRAX添加自選
2.620USD
-0.180-6.43%
收盤 07-31 16:00（美東）報價延遲15分鐘
11.38M總市值
虧損本益比TTM
關於 Virax Biolabs Group Ltd 公司
Virax Biolabs Group Limited is a biotechnology company focused on the detection of immune responses to and diagnosis of viral diseases. The Company is engaged in developing ViraxImmune with the intention of providing an immunology profiling platform that assesses each individual’s immune risk profile against global viral diseases as well as helping with the early diagnosis of post-viral syndromes associated with T cell exhaustion and chronic inflammation. Its product portfolio includes ViraxClear and ViraxVet. ViraxClear offers a range of accurate diagnostic testing kits and machines. ViraxVet offers various rapid and molecular tests for small animal veterinary diagnostics. The Company is initially focused on diseases associated with post-viral syndromes, including SARS-CoV-2, Human Papillomavirus (HPV), Malaria, Hepatitis B, and Herpes (HSV-1).
Virax Biolabs Group Ltd簡介
公司代碼VRAX
公司名稱Virax Biolabs Group Ltd
上市日期Jul 14, 2022
CEOFoster (James)
員工數量19
證券類型Ordinary Share
年結日Jul 14
公司地址Biocity Glasgow
城市LONDON
上市交易所NASDAQ OMX - NASDAQ BASIC
國家United Kingdom
郵編ML1 5UH
電話4402077887414
網址https://www.viraxbiolabs.com
公司代碼VRAX
上市日期Jul 14, 2022
CEOFoster (James)
Virax Biolabs Group Ltd公司高管
名稱
名稱/職務
職務
持股
持股變動
Mr. James Foster
Mr. James Foster
Chairman of the Board, Chief Executive Officer, Principal Accounting Officer, Co-Founder
Chairman of the Board, Chief Executive Officer, Principal Accounting Officer, Co-Founder
16.61K
+30.65%
Mr. Evan Norton
Mr. Evan Norton
Independent Director
Independent Director
880.00
+30.34%
Mr. Nelson M. Haight
Mr. Nelson M. Haight
Independent Director
Independent Director
--
--
Dr. Nigel Mccracken, Ph.D.
Dr. Nigel Mccracken, Ph.D.
Chief Operating Officer, Director
Chief Operating Officer, Director
--
--
Dr. Iain Miller
Dr. Iain Miller
Independent Director
Independent Director
--
--
名稱
名稱/職務
職務
持股
持股變動
Mr. James Foster
Mr. James Foster
Chairman of the Board, Chief Executive Officer, Principal Accounting Officer, Co-Founder
Chairman of the Board, Chief Executive Officer, Principal Accounting Officer, Co-Founder
16.61K
+30.65%
Mr. Evan Norton
Mr. Evan Norton
Independent Director
Independent Director
880.00
+30.34%
Mr. Nelson M. Haight
Mr. Nelson M. Haight
Independent Director
Independent Director
--
--
Dr. Nigel Mccracken, Ph.D.
Dr. Nigel Mccracken, Ph.D.
Chief Operating Officer, Director
Chief Operating Officer, Director
--
--
Dr. Iain Miller
Dr. Iain Miller
Independent Director
Independent Director
--
--
常見問題
Virax Biolabs Group Ltd的前五大股東是誰？
Virax Biolabs Group Ltd的前五大股東如下：Mr. James Foster
有多少機構持有Virax Biolabs Group Ltd(VRAX)的股份？
截至2026Q1，共有22家機構持有Virax Biolabs Group Ltd的股份，合計持有的股份價值約為851.39K，占公司總股份的4.27% 。與2025Q4相比，機構持股有所增加，增幅為268600.00。